Beranda › Kanker Darah › Iowa › Cedar Rapids
Uji klinis Kanker Darah di Cedar Rapids, IA
9 studi untuk Kanker Darah mencari peserta di lokasi sekitar Cedar Rapids (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Menerima pesertaFase 3
- University of Iowa Hospital and Clinics ( Site 0026), Iowa City · 25 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Menerima pesertaStudi observasional
- University of Iowa Hospital and Clinics, Iowa City · 25 mi jauhnya
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- University of Iowa, Iowa City · 25 mi jauhnya
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi jauhnya
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Menerima pesertaFase 1
- University of Iowa, Iowa City · 25 mi jauhnya
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- University of Iowa, Iowa City · 25 mi jauhnya
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Menerima pesertaFase 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi jauhnya
Uji klinis Kanker Darah di kota lain
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Baltimore, MD18 studi
- Seattle, WA18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Atlanta, GA13 studi
- Nashville, TN13 studi
Studi lain di Cedar Rapids
- Kanker Paru Non-Sel Kecil20 studi
- Kanker Payudara17 studi
- Leukemia Mieloid Akut16 studi
- Kanker (semua jenis)15 studi
- Mieloma Multipel15 studi
- Kanker Paru14 studi
- Kanker Kolorektal13 studi
- Kanker Prostat12 studi
- Karsinoma Sel Skuamosa Kepala dan Leher12 studi
- Melanoma10 studi
- Stroke10 studi
- Kanker Metastatik9 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.